These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 6818929)

  • 21. [Pseudomonas aeruginosa. II. Serotyping and virulence of the organism against mice and guinea pigs and its sensitivity to antibiotics].
    Kawaharajo K; Watanabe T; Ishii T; Yamaki S
    Nihon Saikingaku Zasshi; 1973 Nov; 28(6):499-505. PubMed ID: 4207985
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of a polyvalent vaccine against Pseudomonas aeruginosa in severely burned patients].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1984 Apr; 39(17):557-61. PubMed ID: 6435103
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphological study of the organs and tissues of mice infected after a burn with a Pseudomonas aeruginosa strain and treated with a Pseudomonas aeruginosa polyvalent corpuscular vaccine and tobramycin].
    Moroz AF; Kharitonova AM; Chanturiia TsK
    Antibiotiki; 1983 May; 28(5):341-5. PubMed ID: 6410985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis.
    Kipnis E; Sawa T; Wiener-Kronish J
    Med Mal Infect; 2006 Feb; 36(2):78-91. PubMed ID: 16427231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum level of Pseudomonas aeruginosa-specific IgA in patients with chronic lower respiratory tract infection and its clinical significance].
    Tsukada H; Suzuki E; Wada K; Arakawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Oct; 31(10):1227-34. PubMed ID: 8271654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A polyvalent Pseudomonas vaccine.
    Sato H; Diena BB
    Rev Can Biol; 1974 Jun; 33(2):93-7. PubMed ID: 4211759
    [No Abstract]   [Full Text] [Related]  

  • 27. [Our experience with the treatment of burns with sheep serum against Pseudomonas aeruginosa].
    Orłowski T; Struzyna J; Badowski A; Schiller B; Kuntze A; Kozaczek W; Goller W
    Wiad Lek; 1980 Nov; 33(21):1697-701. PubMed ID: 6784349
    [No Abstract]   [Full Text] [Related]  

  • 28. Pseudomonas aeruginosa: prevention better than cure?
    Mellor JA; Miler JJ
    Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
    Hansen CR; Pressler T; Høiby N
    J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of polyvalent vaccine against Pseudomonas aeruginosa in extensive burns].
    Nasiłowski W; Zietkiewicz W; Brudzyńska-Charewicz S; Bukowska D; Serafińska D; Rudowski W
    Pol Tyg Lek; 1981 Aug; 36(32):1207-11. PubMed ID: 6798556
    [No Abstract]   [Full Text] [Related]  

  • 31. [Changing resistance of Pseudomonas aeruginosa isolates from patients with respiratory tract infections].
    Nakamori Y
    Nihon Rinsho; 1991 Oct; 49(10):2393-8. PubMed ID: 1749095
    [No Abstract]   [Full Text] [Related]  

  • 32. Current status of Pseudomonas aeruginosa vaccine.
    Michelim L; Medeiros GS; Zavascki AP
    Curr Pharm Biotechnol; 2013; 14(11):951-9. PubMed ID: 24372247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunotherapy by polyvalent bacterial antigen (broncasma berna) for chronic lower respiratory infectious disease].
    Okano H; Tachibana A; Suzuki K; Nakada K; Tanimoto H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1985 Mar; 23(3):324-31. PubMed ID: 4032874
    [No Abstract]   [Full Text] [Related]  

  • 34. Lung infections. 3. Pseudomonas aeruginosa and other related species.
    Wilson R; Dowling RB
    Thorax; 1998 Mar; 53(3):213-9. PubMed ID: 9659359
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics and epidemiological significance of the Pseudomonas aeruginosa strains isolated in Rumania from sporadic cases and nocosomial infections].
    Meitert E; Meitert T
    Arch Roum Pathol Exp Microbiol; 1972 Sep; 31(3):443-8. PubMed ID: 4198514
    [No Abstract]   [Full Text] [Related]  

  • 36. [Active drugs against Pseudomonas aeruginosa and their clinical usefulness].
    Gobernado M
    Rev Clin Esp; 1998 Sep; 198 Suppl 2():51-61. PubMed ID: 9844479
    [No Abstract]   [Full Text] [Related]  

  • 37. [Controlled trial of a polyvalent antibacterial vaccine in children with recurrent respiratory infections].
    Milano C; Di Fazio A; Bellioni P; Stella A; Aiuti F; Businco L
    Minerva Pediatr; 1980 May; 32(9):641-6. PubMed ID: 7007861
    [No Abstract]   [Full Text] [Related]  

  • 38. [Modern aspects of the treatment of Pseudomonas aeruginosa infection].
    Rozhavin MA
    Antibiotiki; 1980 Apr; 25(4):303-7. PubMed ID: 6768339
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutical pseudomonas aeruginosa antisera. Preparation, control and administration.
    Meitert T; Meitert E; Szegli G; Peligrad I
    Arch Roum Pathol Exp Microbiol; 1982; 41(2):115-21. PubMed ID: 6816189
    [No Abstract]   [Full Text] [Related]  

  • 40. [Urinary tract infection caused by Pseudomonas aeruginosa].
    Shiraiwa Y; Ishibashi K
    Nihon Rinsho; 1991 Oct; 49(10):2399-404. PubMed ID: 1749096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.